GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (OTCPK:VPHIF) » Definitions » Additional Paid-In Capital

Valeo Pharma (Valeo Pharma) Additional Paid-In Capital : $3.46 Mil(As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Valeo Pharma Additional Paid-In Capital?


Valeo Pharma's quarterly additional paid-in capital declined from Jul. 2023 ($3.39 Mil) to Oct. 2023 ($3.34 Mil) but then increased from Oct. 2023 ($3.34 Mil) to Jan. 2024 ($3.46 Mil).

Valeo Pharma's annual additional paid-in capital increased from Oct. 2021 ($1.93 Mil) to Oct. 2022 ($3.22 Mil) and increased from Oct. 2022 ($3.22 Mil) to Oct. 2023 ($3.34 Mil).

Valeo Pharma Additional Paid-In Capital Historical Data

The historical data trend for Valeo Pharma's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Additional Paid-In Capital Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Additional Paid-In Capital
Get a 7-Day Free Trial 0.45 1.22 1.93 3.22 3.34

Valeo Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.62 3.71 3.39 3.34 3.46

Valeo Pharma Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Valeo Pharma Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Valeo Pharma (Valeo Pharma) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (OTCPK:VPHIF) » Definitions » Additional Paid-In Capital
Comparable Companies
XCNQ:CANN TSX:XLY XCNQ:XTRX TSXV:MPH XCNQ:BAMM TSX:CTX NEOE:TILT XCNQ:MVMD XCNQ:VIN XCNQ:PWR ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
VPH:Canada
Address
16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Website
https://www.valeopharma.com
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.